tailieunhanh - Chapter 046. Sodium and Water (Part 18)

Algorithm depicting clinical approach to hyperkalemia. NSAID, nonsteroidal anti-inflammatory drug; ACE, angiotensin-converting enzyme; RTA, renal tubular acidosis; TTKG, transtubular K+ concentration gradient. The appropriate renal response to hyperkalemia is to excrete at least 200 mmol of K+ daily. In most cases, diminished renal K+ loss is due to impaired K+ secretion, which can be assessed by measuring the transtubular K + concentration gradient (TTKG). | Chapter 046. Sodium and Water Part 18 Algorithm depicting clinical approach to hyperkalemia. NSAID nonsteroidal anti-inflammatory drug ACE angiotensin-converting enzyme RTA renal tubular acidosis TTKG transtubular K concentration gradient. The appropriate renal response to hyperkalemia is to excrete at least 200 mmol of K daily. In most cases diminished renal K loss is due to impaired K secretion which can be assessed by measuring the transtubular K concentration gradient TTKG . A TTKG 10 implies a decreased driving force for K secretion due to either hypoaldosteronism or resistance to the renal effects of mineralocorticoid. This can be determined by evaluating the kaliuretic response to administration of mineralocorticoid . 9a-fludrocortisone . Primary adrenal insufficiency can be differentiated from hyporeninemic hypoaldosteronism by examining the renin-aldosterone axis. Renin and aldosterone levels should be measured in the supine and upright positions following 3 days of Na restriction Na intake 10 mmol d in combination with a loop diuretic to induce mild volume contraction. Aldosterone-resistant hyperkalemia can result from the various causes of impaired distal Na reabsorption or from a Cl- shunt. The former leads to salt wasting ECF volume contraction and high renin and aldosterone levels. In contrast enhanced distal Cl- reabsorption is associated with volume expansion and suppressed renin and aldosterone secretion. As mentioned above hypoaldosteronism seldom causes severe hyperkalemia in the absence of increased dietary K intake renal insufficiency transcellular K shifts or antikaliuretic drugs. Hyperkalemia Treatment The approach to therapy depends on the degree of hyperkalemia as determined by the plasma K concentration associated muscular weakness and changes on the electrocardiogram. Potentially fatal hyperkalemia rarely occurs unless the plasma K concentration exceeds mmol L and is usually associated with profound weakness and absent P waves QRS

crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.